Japanese CML Patients' treatment patterns revealed in new study
NCT ID NCT07150793
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 27 times
Summary
This study examined medical records of 754 people with chronic myeloid leukemia (CML) in Japan to see how they were treated with targeted drugs called TKIs. Researchers looked at which drugs were used, how often patients switched or stopped treatment, and the costs involved. The goal was to understand real-world treatment patterns, not to test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOID LEUKEMIA, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.